J0612
J0612 – Injection, calcium gluconate (fresenius kabi), per 10 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 26 NDCs crosswalked per 10 MG $0.027/unit ASP+6%
📋 J0612 summary
J0612 is a HCPCS Level II J-code used to bill calcium gluconate (fresenius kabi), per 10 mg, billed per 10 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J0612: Calcium Gluconate-Nacl(J0612)*, Calcium Gluconate
Code J0612
Billing unit 10 MG Payment limit $0.027/unit NDC-Crosswalk 26
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ0612
DescriptorInjection, calcium gluconate (fresenius kabi), per 10 mg
Billing unit10 MG
Payment limit / unit$0.027
Est. ASP / unit$0.025 est.
Mapped NDCs26
Data periodQ3 2026
Last updated2026-08-20
💊 About Calcium Gluconate DRUG GUIDE
Calcium Gluconate Injection and Calcium Gluconate in Sodium Chloride Injection are both indicated to treat acute symptomatic hypocalcemia — a sudden, serious drop in blood calcium levels that causes symptoms — in adult and pediatric patients, including neonates.
Both products are given intravenously (through a vein) in a hospital or clinical setting.The safety of these injections for long-term use has not been established, so they are intended for short-term treatment of acute episodes.
Clinical overview from our editorial drug guide for Calcium Gluconate. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$0.027
Est. ASP / unit
$0.025 est.
Est. after 2% sequester
$0.026
HCPCS dosage
10 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, calcium gluconate (fresenius kabi), per 10 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment groupYY
Action codeP — Payment change
Effective date2024-01-01
Date added2023-04-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J0612 = 10 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J0612 WITH EST. MEDICARE PAY
26 NDCs map to J0612. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($0.027/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00143-9180-25 | calcium gluconate 98 mg/mL INJECTION, SOLUTION | Hikma | 25 VIAL in 1 CARTON (0143-9180-25) / 10 m... | 98 mg/mL | 2,500 | $67.50 | — | ● Active | CMS + PDAC |
| 00143-9184-25 | calcium gluconate 98 mg/mL INJECTION, SOLUTION | Hikma | 25 VIAL in 1 CARTON (0143-9184-25) / 50 m... | 98 mg/mL | 12,500 | $337.50 | — | ● Active | CMS + PDAC |
| 00143-9185-20 | calcium gluconate 98 mg/mL INJECTION, SOLUTION | Hikma | 20 VIAL in 1 CARTON (0143-9185-20) / 100... | 98 mg/mL | 20,000 | $540.00 | — | ● Active | CMS + PDAC |
| 00404-9764-10 | Calcium Gluconate 98 mg/mL INJECTION, SOLUTION | Henry | 1 VIAL in 1 BAG (0404-9764-10) / 10 mL in... | 98 mg/mL | 100 | $2.70 | — | ● Active | CMS ASP |
| 00404-9831-10 | Calcium Gluconate 98 mg/mL INJECTION, SOLUTION | Henry | 1 VIAL, PLASTIC in 1 BAG (0404-9831-10) /... | 98 mg/mL | 100 | $2.70 | — | ● Active | CMS ASP |
| 00404-9831-50 | Calcium Gluconate 98 mg/mL INJECTION, SOLUTION | Henry | 1 VIAL, PLASTIC in 1 BAG (0404-9831-50) /... | 98 mg/mL | 500 | $13.50 | — | ● Active | CMS ASP |
| 51662-1312-01 | CALCIUM GLUCONATE 98 mg/mL INJECTION, SOLUTION | HF | 10 mL in 1 VIAL, SINGLE-DOSE (51662-1312-1... | 98 mg/mL | 100 | $2.70 | — | ● Active | CMS ASP |
| 63323-0360-19 | Calcium Gluconate 100 mg/mL INJECTION, SOLUTION | Fresenius | 25 VIAL, PLASTIC in 1 TRAY (63323-360-19)... | 100 mg/mL | 2,500 | $67.50 | — | ● Active | CMS + PDAC |
| 63323-0360-59 | Calcium Gluconate 100 mg/mL INJECTION, SOLUTION | Fresenius | 25 VIAL, PLASTIC in 1 TRAY (63323-360-59)... | 100 mg/mL | 12,500 | $337.50 | — | ● Active | CMS + PDAC |
| 63323-0360-61 | Calcium Gluconate 100 mg/mL INJECTION, SOLUTION | Fresenius | 20 VIAL, PLASTIC in 1 TRAY (63323-360-61)... | 100 mg/mL | 20,000 | $540.00 | — | ● Active | CMS + PDAC |
| 65219-0162-10 | Calcium Gluconate 20 mg/mL INJECTION, SOLUTION | Fresenius | 24 BAG in 1 CASE (65219-162-10) / 50 mL i... | 20 mg/mL | 2,400 | $64.80 | — | ● Active | CMS ASP |
| 65219-0164-50 | Calcium Gluconate 20 mg/mL INJECTION, SOLUTION | Fresenius | 24 BAG in 1 CASE (65219-164-50) / 100 mL... | 20 mg/mL | 4,800 | $129.60 | — | ● Active | CMS ASP |
| 65219-0630-19 | Calcium Gluconate 98 mg/mL INJECTION, SOLUTION | Fresenius | 25 VIAL, PLASTIC in 1 TRAY (65219-630-19)... | 98 mg/mL | 2,500 | $67.50 | — | ● Active | CMS + PDAC |
| 70069-0727-10 | CALCIUM GLUCONATE 98 mg/mL INJECTION, SOLUTION | Somerset | 10 VIAL, PLASTIC in 1 CARTON (70069-727-10... | 98 mg/mL | 5,000 | $135.00 | — | ● Active | CMS + PDAC |
| 70069-0727-25 | CALCIUM GLUCONATE 98 mg/mL INJECTION, SOLUTION | Somerset | 25 VIAL, PLASTIC in 1 CARTON (70069-727-25... | 98 mg/mL | 12,500 | $337.50 | — | ● Active | CMS + PDAC |
| 70069-0728-20 | CALCIUM GLUCONATE 98 mg/mL INJECTION, SOLUTION | Somerset | 20 VIAL, PLASTIC in 1 CARTON (70069-728-20... | 98 mg/mL | 20,000 | $540.00 | — | ● Active | CMS + PDAC |
| 75834-0171-19 | Calcium Gluconate | Nivagen | — | — | 2,500 | $67.50 | — | — | CMS + PDAC |
| 80830-1672-02 | calcium gluconate 98 mg/mL INJECTION, SOLUTION | Amneal | 10 VIAL in 1 CARTON (80830-1672-2) / 10 m... | 98 mg/mL | 1,000 | $27.00 | — | ● Active | CMS + PDAC |
| 80830-1673-02 | calcium gluconate 98 mg/mL INJECTION, SOLUTION | Amneal | 10 VIAL in 1 CARTON (80830-1673-2) / 50 m... | 98 mg/mL | 5,000 | $135.00 | — | ● Active | CMS + PDAC |
| 80830-1674-02 | calcium gluconate 98 mg/mL INJECTION, SOLUTION | Amneal | 10 VIAL, PHARMACY BULK PACKAGE in 1 CARTON... | 98 mg/mL | 10,000 | $270.00 | — | ● Active | CMS + PDAC |
| 80830-2362-02 | CALCIUM GLUCONATE 20 mg/mL INJECTION, SOLUTION | Amneal | 12 POUCH in 1 CARTON (80830-2362-2) / 1 B... | 20 mg/mL | 1,200 | $32.40 | — | ● Active | CMS ASP |
| 80830-2362-09 | CALCIUM GLUCONATE 20 mg/mL INJECTION, SOLUTION | Amneal | 24 POUCH in 1 CARTON (80830-2362-9) / 1 B... | 20 mg/mL | 2,400 | $64.80 | — | ● Active | CMS ASP |
| 80830-2363-02 | CALCIUM GLUCONATE 20 mg/mL INJECTION, SOLUTION | Amneal | 12 POUCH in 1 CARTON (80830-2363-2) / 1 B... | 20 mg/mL | 2,400 | $64.80 | — | ● Active | CMS ASP |
| 80830-2363-09 | CALCIUM GLUCONATE 20 mg/mL INJECTION, SOLUTION | Amneal | 24 POUCH in 1 CARTON (80830-2363-9) / 1 B... | 20 mg/mL | 4,800 | $129.60 | — | ● Active | CMS ASP |
| 70069-0728-10 | CALCIUM GLUCONATE 98 mg/mL INJECTION, SOLUTION | Somerset | 10 VIAL, PLASTIC in 1 CARTON (70069-728-10... | 98 mg/mL | 10 | $0.27 | — | ● Active | PDAC |
| 00264-5600-52 | Calcium Gluconate 98 mg/mL INJECTION, SOLUTION | B. | 24 CONTAINER in 1 CASE (0264-5600-52) / 1... | 98 mg/mL | 10 | $0.27 | — | ● Active | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$5.2K
Claims
2,730
Beneficiaries
746
Spend / beneficiary
$7.01
Spend / claim
$1.92
Trend by period
Where J0612 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #709 of 824
#704
ORPHENADRINE CITRATE J2360
$6.1K
#705
HYLENEX J3473
$6K
#706
NOVACHOR 1 SQ CM** Q4194
$5.7K
#707
MITOXANTRONE HCL J9293
$5.6K
#708
NEBUPENT(J2516)* J2516
$5.4K
#709
CALCIUM GLUCONATE-NA... J0612
$5.2K
#710
DELESTROGEN* J1380
$5.1K
#711
SYNOJOYNT, INJ., 1 M... J7331
$4.5K
#712
FUROSEMIDE(J1938) J1938
$4.2K
#713
AMIKACIN SULFATE J0278
$4.2K
#714
CLOFARABINE* J9027
$4.1K
Total claims — #277 of 824
#272
ONIVYDE J9205
2,939
#273
PURAPLY AM 1 SQ CM** Q4196
2,848
#274
KERECIS OMEGA3, PER... Q4158
2,810
#275
GRAFIX STRAVIX PRIME... Q4133
2,788
#276
VANCOMYCIN HCL-0.9%... J3373
2,740
#277
CALCIUM GLUCONATE-NA... J0612
2,730
#278
ELAHERE J9063
2,700
#279
BORUZU J9054
2,691
#280
DYSPORT J0586
2,683
#281
IDOSE TR J7355
2,681
#282
DARZALEX J9145
2,647
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $5.2K | 746 | 2,730 | $7.01 | $1.92 |
| 2025 (Q1-Q4) | $26K | 1,884 | 9,029 | $13.82 | $2.88 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$26.3K
Medicare paid
$20.1K
Submitted services
740,328
Denial rate
12.2%
Allowed / service
$0.04
Submitted charges
$1.23M
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J0612 is utilized CMS · BY PROVIDER · 2024
Medicare Part B services for this code by the rendering provider's state — 192,853 services across 10 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.
Hover or tap a state to see its numbers + top ZIP codes.
Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.
📊 What bills under J0612
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
26 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J0612 billing FAQ
What is HCPCS code J0612?
J0612 is a HCPCS Level II J-code used to bill Injection, calcium gluconate (fresenius kabi), per 10 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J0612?
One unit of J0612 represents 10 MG. Report the number of units equal to the dose administered divided by 10 MG.
How many units of J0612 should I bill?
Divide the dose administered by the code's unit size (10 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J0612?
The Medicare Part B payment limit is $0.027 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.026 per unit. Payment limits are revised quarterly.
Which NDCs bill under J0612?
26 NDCs currently map to J0612 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J0612 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.